نتائج البحث

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution.

• Authors : Deora N; ICMR-National Institute of Malaria Research, New Delhi, India.; Sinha A

Subjects: Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/pharmacology ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/pharmacology

• Source: Malaria journal [Malar J] 2024 Jul 24; Vol. 23 (1), pp. 219. Date of Electronic Publication: 2024 Jul 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

Using the role model approach to optimise caregiver administration of sulfadoxine-pyrimethamine amodiaquine to children aged 3-59 months in Burkina Faso, Chad and Togo: findings from an evaluation.

• Authors : Donovan L; Malaria Consortium, London, UK.; Shafique M

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/administration & dosage ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Caregivers*/Caregivers*/Caregivers*/psychology

• Source: Malaria journal [Malar J] 2024 Aug 24; Vol. 23 (1), pp. 255. Date of Electronic Publication: 2024 Aug 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

Determinants of the optimal uptake of sulfadoxine-pyrimethamine doses for intermittent treatment of malaria in pregnancy in urban Nigeria.

• Authors : Adeojo OS; Department of Sociology, University of Ibadan, Ibadan, Nigeria. .; Fayehun O

Subjects: Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/administration & dosage ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/therapeutic use

• Source: Scientific reports [Sci Rep] 2024 Aug 17; Vol. 14 (1), pp. 19097. Date of Electronic Publication: 2024 Aug 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.

• Authors : Cellich P; Division of Obstetrics and Gynaecology, School of Medicine and Health Sciences, Port Moresby General Hospital, University of Papua New Guinea, Port Moresby, Papua New Guinea. .; Department of Obstetrics and Gynaecology, Canterbury Hospital, 575 Canterbury Road, Campsie 2194, NSW, Australia. .

Subjects: Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/administration & dosage ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/therapeutic use

• Source: Malaria journal [Malar J] 2024 Jul 05; Vol. 23 (1), pp. 201. Date of Electronic Publication: 2024 Jul 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.

• Authors : Obonyo CO; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya. .; Rawago FO

Subjects: Praziquantel*/Praziquantel*/Praziquantel*/administration & dosage ; Praziquantel*/Praziquantel*/Praziquantel*/adverse effects ; Praziquantel*/Praziquantel*/Praziquantel*/therapeutic use

• Source: Parasites & vectors [Parasit Vectors] 2024 Jun 28; Vol. 17 (1), pp. 279. Date of Electronic Publication: 2024 Jun 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101462774 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-3305

تفاصيل العنوان

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

• Authors : Tilde Sciences

• Source: Early Phase I Window of Opportunity Biomarker and Safety Trial to Test Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated, Locally Advanced Head and Neck Squamous

تفاصيل العنوان

Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth

• Authors : Academy of Finland; Foundation for Paediatric Research, Finland; Per Ashorn, Professor of Pediatrics

• Source: Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3

تفاصيل العنوان

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy (SAPOT)

• Authors : Papua New Guinea Institute of Medical Research; University of Melbourne; Curtin University

• Source: Intermittent Preventive Treatment in Pregnancy With Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine to Prevent Malaria Infection and Reduce Adverse

تفاصيل العنوان

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution

• Authors : Nimita Deora; Abhinav Sinha

Subjects: Malaria; Sulfadoxine-pyrimethamine resistance; Molecular markers

• Source: Malaria Journal, Vol 23, Iss 1, Pp 1-3 (2024)

تفاصيل العنوان

Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial

• Authors : Charles O. Obonyo; Fredrick O. Rawago; Nicholas K. Makworo

Subjects: Schistosomiasis; Praziquantel; Artesunate plus sulfalene-pyrimethamine

• Source: Parasites & Vectors, Vol 17, Iss 1, Pp 1-12 (2024)

تفاصيل العنوان